289 related articles for article (PubMed ID: 17531410)
21. The age at menopause and associated factors at the health center area in Ankara, Turkey.
Ozdemir O; Cöl M
Maturitas; 2004 Nov; 49(3):211-9. PubMed ID: 15488349
[TBL] [Abstract][Full Text] [Related]
22. Risk of onset of menopausal symptoms in periods surrounding menopause.
Sabia S; Fournier A; Mesrine S; Boutron-Ruault MC; Clavel-Chapelon F
Maturitas; 2007 Dec; 58(4):340-7. PubMed ID: 17981410
[TBL] [Abstract][Full Text] [Related]
23. Factors associated with bone density in young women with karyotypically normal spontaneous premature ovarian failure.
Leite-Silva P; Bedone A; Pinto-Neto AM; Costa JV; Costa-Paiva L
Arch Gynecol Obstet; 2009 Aug; 280(2):177-81. PubMed ID: 19104824
[TBL] [Abstract][Full Text] [Related]
24. Maintenance of ovarian function and risk of premature menopause related to cancer treatment.
Sklar C
J Natl Cancer Inst Monogr; 2005; (34):25-7. PubMed ID: 15784817
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms of premature ovarian failure.
Santoro N
Ann Endocrinol (Paris); 2003 Apr; 64(2):87-92. PubMed ID: 12773939
[TBL] [Abstract][Full Text] [Related]
26. The timing of natural menopause in Poland and associated factors.
Kaczmarek M
Maturitas; 2007 Jun; 57(2):139-53. PubMed ID: 17307314
[TBL] [Abstract][Full Text] [Related]
27. Analysis of the molecular parameters that could predict the risk of manifesting premature ovarian failure in female premutation carriers of fragile X syndrome.
Tejada MI; García-Alegría E; Bilbao A; Martínez-Bouzas C; Beristain E; Poch M; Ramos-Arroyo MA; López B; Fernandez Carvajal I; Ribate MP; Ramos F
Menopause; 2008; 15(5):945-9. PubMed ID: 18427356
[TBL] [Abstract][Full Text] [Related]
28. Premature menopause: a comprehensive understanding of psychosocial aspects.
Deeks AA; Gibson-Helm M; Teede H; Vincent A
Climacteric; 2011 Oct; 14(5):565-72. PubMed ID: 21854296
[TBL] [Abstract][Full Text] [Related]
29. Early menopause, low body mass index, and smoking are independent risk factors for developing giant cell arteritis.
Larsson K; Mellström D; Nordborg E; Odén A; Nordborg E
Ann Rheum Dis; 2006 Apr; 65(4):529-32. PubMed ID: 16126796
[TBL] [Abstract][Full Text] [Related]
30. Estrogen receptor alpha gene polymorphisms are associated with idiopathic premature ovarian failure.
Bretherick KL; Hanna CW; Currie LM; Fluker MR; Hammond GL; Robinson WP
Fertil Steril; 2008 Feb; 89(2):318-24. PubMed ID: 17706202
[TBL] [Abstract][Full Text] [Related]
31. [Spontaneous pregnancies and premature menopause].
Letur H; Martin-Pont B; Fénichel P;
Gynecol Obstet Fertil; 2004 Sep; 32(9):748-55. PubMed ID: 15380757
[TBL] [Abstract][Full Text] [Related]
32. "Coming to grips" with chemotherapy-induced premature menopause.
Knobf MT
Health Care Women Int; 2008 Apr; 29(4):384-99. PubMed ID: 18389434
[TBL] [Abstract][Full Text] [Related]
33. Menstrual and reproductive factors in the risk of differentiated thyroid carcinoma in native women in French Polynesia: a population-based case-control study.
Brindel P; Doyon F; Rachédi F; Boissin JL; Sebbag J; Shan L; Chungue V; Sun LY; Bost-Bezeaud F; Petitdidier P; Paoaafaite J; Teuri J; de Vathaire F
Am J Epidemiol; 2008 Jan; 167(2):219-29. PubMed ID: 17965111
[TBL] [Abstract][Full Text] [Related]
34. Ovarian cysts and breast cancer: results from the Women's Contraceptive and Reproductive Experiences Study.
Knight JA; Lesosky M; Blackmore KM; Voigt LF; Holt VL; Bernstein L; Marchbanks PA; Burkman RT; Daling JR; Whittemore AS
Breast Cancer Res Treat; 2008 May; 109(1):157-64. PubMed ID: 17616808
[TBL] [Abstract][Full Text] [Related]
35. Do etiologies of premature ovarian aging (POA) mimic those of premature ovarian failure (POF)?
Gleicher N; Weghofer A; Oktay K; Barad D
Hum Reprod; 2009 Oct; 24(10):2395-400. PubMed ID: 19617205
[TBL] [Abstract][Full Text] [Related]
36. Early menopause: primary ovarian insufficiency and surgical menopause.
Kodaman PH
Semin Reprod Med; 2010 Sep; 28(5):360-9. PubMed ID: 20845236
[TBL] [Abstract][Full Text] [Related]
37. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
[TBL] [Abstract][Full Text] [Related]
38. Symptoms reported by women in midlife: menopausal transition or aging?
Berecki-Gisolf J; Begum N; Dobson AJ
Menopause; 2009; 16(5):1021-9. PubMed ID: 19546824
[TBL] [Abstract][Full Text] [Related]
39. Acceptance of fragile X premutation genetic screening in women with ovarian dysfunction.
Pastore LM; Karns LB; Pinkerton JV; Silverman LM; Williams CD; Camp TR
Am J Obstet Gynecol; 2006 Mar; 194(3):738-43. PubMed ID: 16522406
[TBL] [Abstract][Full Text] [Related]
40. Age at natural menopause in Spain and the United States: results from the DAMES project.
Reynolds RF; Obermeyer CM
Am J Hum Biol; 2005; 17(3):331-40. PubMed ID: 15849704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
